India to Morocco: Oxaliplatin Export Trade Route

The India to Morocco Oxaliplatin corridor is one of India's established pharmaceutical export routes, with 43 shipments documented worth a combined $1.1M USD. The route is dominated by ACCURE LABS PRIVATE LIMITED, which alone accounts for roughly 66% of all export value, reflecting the consolidated nature of India's oxaliplatin manufacturing sector.

Across 6 active suppliers, the average shipment value stands at $26.3K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (69%) and air (18%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.

Shipment activity peaks during April–June, with an average transit time of 28 days port-to-port. The route has recorded an annual growth rate of 26.2%, placing it at rank #2 among India's top oxaliplatin export destinations globally.

On the import side, key buyers of Indian oxaliplatin in Morocco include NA, To The Order, MS SUN PHARMACEUTICALS MOROCCO LL and 10 others. NA is the single largest importer with 13 shipments valued at $315.3K USD.

India's oxaliplatin exports to Morocco are driven primarily by a handful of large-scale manufacturers. ACCURE LABS PRIVATE LIMITED with 24 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 6 active exporters signals a competitive but concentrated market — buyers in Morocco benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — ACCURE LABS PRIVATE LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED, VENUS REMEDIES LIMITED — together account for 96% of total trade value on this route. The average shipment value of $26.3K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as xylatin 100 private oxaliplatin for injection batch no ox230301b mfg dt mar 2023 exp dt feb 2025 and xylatin 100 mg private oxaliplatin forinjection 100 mg batch no ox230302b mfg dt mar 2023 exp dt feb 2025, suggesting that buyers in Morocco tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, NA is the largest importer with 13 shipments worth $315.3K USD — representing 28% of all oxaliplatin imports from India on this route. A total of 13 buyers are active on this corridor.